Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family
Author(s) -
Chen Wang,
Daniel M. Konecki,
David C. Marciano,
Harikumar Govindarajan,
Amanda M. Williams,
Brigitta Wastuwidyaningtyas,
Thomas Bourquard,
Panagiotis Katsonis,
Olivier Lichtarge
Publication year - 2021
Publication title -
bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.599
H-Index - 390
eISSN - 1367-4811
pISSN - 1367-4803
DOI - 10.1093/bioinformatics/btab406
Subject(s) - identification (biology) , covid-19 , proteome , coronavirus , biology , virology , computational biology , immune escape , coronavirus infections , betacoronavirus , genetics , medicine , immune system , outbreak , infectious disease (medical specialty) , disease , pathology , botany
Since the first recognized case of COVID-19, more than 100 million people have been infected worldwide. Global efforts in drug and vaccine development to fight the disease have yielded vaccines and drug candidates to cure COVID-19. However, the spread of SARS-CoV-2 variants threatens the continued efficacy of these treatments. In order to address this, we interrogate the evolutionary history of the entire SARS-CoV-2 proteome to identify evolutionarily conserved functional sites that can inform the search for treatments with broader coverage across the coronavirus family.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom